A major breakthrough in cancer study is emerging with the use of mini-antibodies to reactivate mutated p53. This crucial cancer suppressor protein is frequently disabled in several kinds of malignancies, resulting https://userbookmark.com/story21881590/vhh-fragments-revive-tumor-suppressor-p53-the-new-approach-for-cancer-therapy